As of 4:00pm ET
| -0.16 / -2.74%|
The 4 analysts offering 12-month price forecasts for Veracyte Inc have a median target of 9.00, with a high estimate of 13.00 and a low estimate of 8.00. The median estimate represents a +58.17% increase from the last price of 5.69.
The current consensus among 5 polled investment analysts is to Buy stock in Veracyte Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.